Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subcutaneous midazolam for sedation in pediatric diagnostic procedures
IRCT20171030037093N20Phase 2Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of midazolam in procedural sedation and analgesia (PSA), sponsored by Isfahan University of Medical Sciences. Started Oct 2019; status: completed.
02
Drugs
midazolam
03
Conditions
procedural sedation and analgesia (PSA)
Beyond the preview
Go deeper on IRCT20171030037093N20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20171030037093N20.